Seasonal and geographic variations in the incidence of asthma exacerbations in the United States

Journal of Asthma

Volumn 54, Issue 8, 2017, Pages 818-824

  Gerhardsson de Verdier, M ^a   Gustafson, Per ^a   McCrae, Christopher ^a   Edsbäcker, Staffan ^a   Johnston, Neil ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Asthma exacerbations; epidemiology; United States

Indexed keywords

CORTICOSTEROID;

ADMINISTRATIVE CLAIMS (HEALTH CARE); ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CIRCANNUAL RHYTHM; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HOSPITAL CARE; HUMAN; ICD-9; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; RETROSPECTIVE STUDY; SEASONAL VARIATION; STEROID THERAPY; SUMMER; UNITED STATES; DEMOGRAPHY; INSURANCE; MIDDLE AGED; PATHOPHYSIOLOGY; SEASON; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; CHILD; FEMALE; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 85012069936     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770903.2016.1277538     Document Type: Article

References (34)

1. Akinbami L, Moorman J, Bailey C, Zahran HS, King M, Johnson CA, et al. Trends in asthma prevalence, health care use, and mortality: United States, 2001–2010. NCHS data brief, no 94. Hyattsville, MD: National Center for Health Statistics; 2012. http://www.cdc.gov/nchs/data/databriefs/db94.pdf.
2. Centers for Disease Control and Prevention. Asthma in the U.S. Vital Signs. Updated May 2011. Available at: http://www.cdc.gov/vitalsigns/Asthma/ [Accessed February13, 2012].
3. Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol 2012; 129(5): 1229– 1235.
4. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 2007; 119: 1454– 1461.
5. Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo C, Gern J, et al. Asthma outcomes: exacerbations. J Allergy Clin Immunol 2012; 129(3 Suppl): S34– S48.
6. Szefler SJ, Chmiel JF, Fitzpatrick AM, Giacoia G, Green TP, Jackson DJ, et al. Asthma across the ages: knowledge gaps in childhood asthma. J Allergy Clin Immunol 2014; 133(1): 3– 13; quiz 14. doi: 10.1016/j.jaci.2013.10.018, Epub 2013 Nov 28. Review.
7. Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O. Asthma and Chronic Obstructive Disease Overlap Syndrome: doubled costs compared with patients with asthma alone. Value Health 2015; 18: 759– 766.
8. National surveillance of asthma: United States, 2001–2010. (Vital and health statistics. Series 3, Analytical and epidemiological studies; Number 35) (HHS publication; no. (PHS) 2013-1419) “ November 2012.
9. Lambert HP, Stern H. Infective factors in exacerbations of bronchitis and asthma. BMJ 1972; 3: 323– 327.
10. Minor TE, Dick EC, DeMeo AN, Ouellette JJ, Cohen M, Reed CE. Viruses as precipitants of asthmatic attacks in children. JAMA 1974; 227: 292– 298.
11. Maimonides M. In: Suessman, Muntner, ed. Treatise on asthma. Philadelphia: JB Lippincott; 1963: 1– 2.
12. Floyer JA. A treatise of the asthma. Second Edition. Printed for R. Wilkin and W. Innys; 1717.
13. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996; 154: 654– 660.
14. Johnston NW, Sears MR. The epidemiology of asthma exacerbations. Thorax 2006; 61: 722– 728.
15. 2LEN-DARE systematic review. Allergy 2011; 66: 458– 468.
16. Busse WW, Lemanske RF, Gern JF. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376: 826– 834.
17. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161(5): 1501– 1507.
18. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352(17): 1749– 1759.
19. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1994; 307: 982– 986.
20. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005; 116(2): 267– 273.
21. Dhariwal J, Edwards MR, Johnston SL. Anti-viral agents: potential utility in exacerbations of asthma. Curr Opin Pharmacol 2013; 13: 331– 336.
22. Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: doubled costs compared with patients with asthma alone. Value Health 2015: 18; 759– 766.
23. Battaglia S, Basile M, Spatafora M, Scichilone N. Are asthmatics enrolled in randomised trials representative of real-life outpatients? Respiration 2015; 89: 383– 389.
24. Szefler SJ, Chmiel JF, Fitzpatrick AM, Giacoia G, Green TP, Jackson DJ, et al. Asthma across the ages: knowledge gaps in childhood asthma. J Allergy Clin Immunol 2014; 133: 3– 13.
25. Johnston NW, Johnston SL, Dai J, Norman GR, Sears MR. The september epidemic of asthma exacerbations: school children as disease vectors. J Allergy Clin Immunol 2006; 117: 557– 562.
26. Johnston NW. The similarities and differences of epidemic cycles of COPD and asthma exacerbations. Proceedings of the American Thoracic Society 2007; 4: 591– 596.
27. Gerke AK, Yang M, Tang F, Foster ED, Cavanaugh JE, Polgreen PM. Association of hospitalizations for asthma with seasonal and pandemic influenza. Respirology 2014; 19: 116– 121.
28. Ivey M, Simeon D, Juman S, Hassanally R, Williams K, Monteil M. Associations between climate variables and asthma visits to accident and emergency facilities in Trinidad, West Indies. Allergol Int 2001; 50: 29– 33.
29. Hasegawa K, Sullivan AF, Tsugawa Y, Turner SJ, Masara S, Clark S, et al. Comparison of US emergency department acute asthma care quality; 1997–2001 and 2011–2012. J Allergy Clin Immunol 2015; 135: 75– 80.
30. Dales RE, Cakmak S, Judek S, Dann T, Coates F, Brook JR, et al. Influence of outdoor aeroallergens on hospitalization for asthma in Canada. J Allergy Clin Immunol 2004; 113: 303– 306.
31. Higham J, Venables K, Kupek E, Bajekal M, Kupek E. Asthma and thunderstorms: description of an epidemic in general practice in Britain using data from a doctor's deputising service in the UK. J Epidemiol Community Health 1997; 51: 233– 238.
32. Dales RE, Cakmak S, Judek S, Dann T, Coates F, Brook JR, et al. The role of fungal spores in thunderstorm asthma. Chest 2003; 123: 745– 750.
33. Marks GB, Colquhoun JR, Girgis ST, Koski MH, Treloar AB, Hansen P, et al. Thunderstorm outflows preceding epidemics of asthma during spring and summer. Thorax 2001; 56: 468– 471.
34. Pulimood TB, Corden JM, Bryden C, Sharples L, Nasser SM. Epidemic asthma and the role of the fungal mold Alternaria alternate. J Allergy Clin Immunol 2007; 120: 610– 617.